Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
09/2010
09/22/2010CN101081234B Method for preparation of claybank propolis soft capsules
09/22/2010CN101032479B Ranitidine bismuth citrate medicine and its preparing process
09/21/2010US7799897 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
09/21/2010US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
09/21/2010US7799787 pyridazine derivatives such as N-(2-Cyclopropylethyl)-6-{4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl}pyridazine-3-carboxamide, useful for the prevention and treatment of dyslipidemia, obesity, diabetes, syndrome X, insulin resistance, fatty liver, cancer, cardiovascular and nervous system disorders
09/21/2010US7799786 Therapeutic agents useful for treating pain
09/21/2010US7799775 Pyrimidine derivatives
09/21/2010US7799763 Muscle-strengthening drugs and anti-inflammatory drugs
09/21/2010US7799353 Pharmaceutical mixture for hepatitis treatment and its preparation method
09/21/2010CA2440559C Novel non-imidazole compounds
09/21/2010CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/21/2010CA2434178C Substituted amine derivatives and methods of use
09/21/2010CA2429308C Novel lactam-substituted pyrazolopyridine derivatives
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/21/2010CA2343074C Akt nucleic acids, polypeptides, and uses thereof
09/21/2010CA2307142C N-terminally chemically modified protein compositions and methods
09/16/2010WO2010105207A1 Prebiotic oligosaccharides
09/16/2010WO2010104309A2 Compositions for preventing or improving gastrointestinal diseases
09/16/2010WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010WO2010104187A1 Steroid compound
09/16/2010WO2010104175A1 Composition for oral administration
09/16/2010WO2010104114A1 Method for preparing polypeptide library
09/16/2010WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010WO2010103843A1 External preparation containing analgesic/anti-inflammatory agent
09/16/2010WO2010103132A1 Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk
09/16/2010WO2010102554A1 New crystalline form vi of agomelatine, preparation method and application thereof
09/16/2010WO2010102387A1 Interleukin-12 polymorphisms for identifying risk for primary biliary cirrhosis
09/16/2010WO2010082689A3 Gip-increase inhibitor
09/16/2010WO2010070672A3 Phytochemical composition comprising cafeic acid derivatives
09/16/2010WO2010056080A3 A composition comprising the extract of rumex aquaticus herba for the prevention and treatment of gastritis disease or ulcer disease and the use thereof
09/16/2010US20100234599 Method for preparing acid addition salts of polyacidic basic compounds
09/16/2010US20100234461 Compositions For Improved Oxidative Status In Companion
09/16/2010US20100234449 Immunostimulatory Method
09/16/2010US20100234448 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100234438 Therapeutic agents
09/16/2010US20100234430 Methods and pharmaceutical formulations for protecting pharmaceutical compounds from acidic environments
09/16/2010US20100234427 1-phenethylpiperidine derivatives and their use as opioid receptor ligands
09/16/2010US20100234426 Phenylpropionamide Compounds and the Use Thereof
09/16/2010US20100234387 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals
09/16/2010US20100234384 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
09/16/2010US20100234373 Bis-aryl amide compounds and methods of use
09/16/2010US20100234367 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010US20100234353 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
09/16/2010US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
09/16/2010US20100234341 Substituted pyrimidines as adenosine receptor antagonists
09/16/2010US20100234340 Substituted Spiroamide Compounds
09/16/2010US20100234334 Nitric oxide releasing steroids
09/16/2010US20100234333 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234332 Novel quinuclidine derivatives and medicinal compositions containing the same
09/16/2010US20100234317 Use of difructose anhydride-containing composition
09/16/2010US20100234301 Methods and Compositions for the Treatment of Gastrointestinal Disorders
09/16/2010US20100234286 Preterm formula
09/16/2010US20100233810 In vivo production of small interfering rnas that mediate gene silencing
09/16/2010US20100233808 Liver tissue source
09/16/2010US20100233722 Methods for determining the biological effect and/or activity of r pharmaceutical compositions based on their effect on the methylation status of the DNA
09/16/2010US20100233290 Use of difructose anhydride-containing composition
09/16/2010US20100233286 Preparations of suspensions
09/16/2010US20100233280 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
09/16/2010US20100233274 Means and methods for enhancing weight gain in poultry
09/16/2010US20100233218 Combination enzyme for cystic fibrosis
09/16/2010US20100233188 Antibodies and pharamcetical compositions containing same useful for inhibiting activity of metalloproteins
09/16/2010US20100233185 Caries Risk Test for Predicting and Assessing the Risk of Disease
09/16/2010US20100233169 Methods for treating obesity using fibroblast growth factor-Like polypeptides
09/16/2010US20100233162 LOCAL ADMINISTRATION OF CHICKEN YOLK IMMUNE GLOBULINS (IgY) TO TREAT AND PREVENT FUNGAL INFECTIONS
09/16/2010US20100233153 Novel gene disruptions, compositions and the methods relating thereto
09/16/2010US20100233122 Novel benzimidazole derivatives
09/16/2010US20100233118 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
09/16/2010US20100233101 Composition and method for the oxidative consumption of salivary biomolecules
09/16/2010US20100233079 Dual Variable Domain Immunoglobulins and Uses Thereof
09/16/2010DE112008002647T5 Antidiarrhöische Zusammensetzung, Produkte, die diese enthalten, und Verfahren zum Schutz vor Diarrhö Antidiarrheal composition, products containing them, and methods for protection against diarrhea
09/16/2010CA2760999A1 Prebiotic oligosaccharides
09/16/2010CA2755120A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors
09/16/2010CA2754613A1 Piperazine compound capable of inhibiting prostaglandin d synthase
09/16/2010CA2754589A1 Steroid compound
09/16/2010CA2754276A1 New crystalline form vi of agomelatine, preparation method and application thereof
09/15/2010EP2228421A2 Compositions containing fluorine substituted olefins
09/15/2010EP2228389A2 Antibodies against vascular endothelial growth factor 2
09/15/2010EP2228065A2 Heterocyclo inhibitors of potassium channel function
09/15/2010EP2227234A1 Method for inducing hepatocyte proliferation and uses thereof
09/15/2010EP1805177B9 Pyrrolo[3,2-c]pyridine derivatives and process for the preparation thereof
09/15/2010EP1758596B9 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
09/15/2010EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1250055B1 Immune modulation with death receptor-induced apoptosis
09/15/2010CN1954859B Mongolia medicine composition for treating chronic cholecystitis, cholecystalgia and its method
09/15/2010CN1911237B Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b
09/15/2010CN1907321B Medicinal composition for treating exterior deficiency and preparation method thereof
09/15/2010CN101835896A Production and use of epitope-tagged hepatitis c virus particle
09/15/2010CN101835892A CDCA1 peptide and pharmaceutical agent comprising the same
09/15/2010CN101835774A Co-crystals and pharmaceutical compositions comprising the same
09/15/2010CN101835478A Laxative agent
09/15/2010CN101831478A Preparation method of 5'-acylate uridine and application in preparing medicaments for treating heart diseases and liver diseases
09/15/2010CN101831461A Human small RNA-148a expression vector and use thereof
09/15/2010CN101831411A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
09/15/2010CN101831378A Vinegar and brewing technology thereof
09/15/2010CN101831375A Preparation method of fragrant white spirit
09/15/2010CN101831370A Method for brewing wine by using abrus herb and cassia mimosoides
09/15/2010CN101831351A Method for extracting ganoderma oil with supercritical carbon dioxide fluid
09/15/2010CN101830957A Process for preparing ginsenosides Rh2 and Rh3 from stems and leaves of pseudoginseng root
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 1258